NFYA expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.3028245976775E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.08970000001207E-06 |
Normal-vs-Stage2 |
1.027460E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
8.352900E-04 |
Stage1-vs-Stage2 |
7.043800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
6.670300E-02 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
1.232600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.42139649944784E-11 |
Normal-vs-AfricanAmerican |
3.132800E-01 |
Normal-vs-Asian |
1.02170000004786E-06 |
Caucasian-vs-AfricanAmerican |
4.209400E-01 |
Caucasian-vs-Asian |
5.709800E-01 |
AfricanAmerican-vs-Asian |
4.025000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.75810000000643E-05 |
Normal-vs-Female |
3.11659997809244E-09 |
Male-vs-Female |
9.338800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.584300E-04 |
Normal-vs-Extreme_Weight |
1.87694999999044E-05 |
Normal-vs-Obese |
6.966300E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
8.027400E-01 |
Normal_Weight-vs-Obese |
3.297400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
4.657800E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.617010E-01 |
Normal-vs-Age(41-60Yrs) |
1.800250E-04 |
Normal-vs-Age(61-80Yrs) |
4.88560000233562E-08 |
Normal-vs-Age(81-100Yrs) |
3.724200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.871200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.786600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.135600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.094600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.785800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.783400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
5.687400E-01 |
Normal-vs-Grade 3 |
7.141600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
5.920400E-01 |
Grade 2-vs-Grade 4 |
5.687400E-01 |
Grade 3-vs-Grade 4 |
7.141600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.60679971737E-10 |
Normal-vs-N1 |
2.316100E-03 |
N0-vs-N1 |
3.462900E-03 |
|
|